Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab in Refractory Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
- Status
- COMPLETED
- Phase
- PHASE2